metyrapone has been researched along with Cafe-au-Lait Spots in 1 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Cafe-au-Lait Spots: Light brown pigmented macules associated with NEUROFIBROMATOSIS and Albright's syndrome (see FIBROUS DYSPLASIA, POLYOSTOTIC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The baby girl underwent medical treatment of Cushing's syndrome with metyrapone which was followed by a rapid recovery." | 1.42 | Neonatal McCune-Albright syndrome with systemic involvement: a case report. ( Dias, P; Gouveia, R; Lourenço, R; Oliveira, G; Sousa, AB, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lourenço, R | 1 |
| Dias, P | 1 |
| Gouveia, R | 1 |
| Sousa, AB | 1 |
| Oliveira, G | 1 |
1 other study available for metyrapone and Cafe-au-Lait Spots
| Article | Year |
|---|---|
Neonatal McCune-Albright syndrome with systemic involvement: a case report.
Topics: Cafe-au-Lait Spots; Cushing Syndrome; Diagnosis, Differential; Failure to Thrive; Fatal Outcome; Fem | 2015 |